Leveraging lessons learned from the commercialization and distribution of rare products for cell and gene therapy

In an interview with Pharm Exec Associate Editor Don Tracy and Vice President of Emerging Therapies Melissa Lattanzi, Cencora talks about how cell and gene therapy developers can follow the example of orphan drug commercialization and distribution.